BARCLAYS PLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 90 filers reported holding HUMACYTE INC in Q4 2023. The put-call ratio across all filers is 1.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q2 2024$409
+96.6%
85,284
+27.4%
0.00%
Q1 2024$208
-24.6%
66,965
-31.1%
0.00%
Q4 2023$276
+294.3%
97,187
+308.6%
0.00%
Q3 2023$70
-65.5%
23,788
-66.4%
0.00%
Q2 2023$203
+49.3%
70,843
+60.1%
0.00%
Q1 2023$136
+115.9%
44,252
+47.0%
0.00%
Q4 2022$63
-99.9%
30,107
+99.8%
0.00%
Q3 2022$49,0000.0%15,071
-0.9%
0.00%
Q2 2022$49,000
-52.4%
15,208
+4.4%
0.00%
Q1 2022$103,00014,5610.00%
Other shareholders
HUMACYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Endowment Wealth Management, Inc. 100,518$482,4860.35%
Monashee Investment Management LLC 280,000$1,344,0000.17%
United Asset Strategies, Inc. 218,308$1,047,8780.10%
HAMILTON LANE ADVISORS LLC 21,893$105,0860.08%
GSA CAPITAL PARTNERS LLP 224,179$1,0760.08%
David J Yvars Group 22,750$109,2000.07%
ARS Investment Partners, LLC 116,419$558,8110.05%
EntryPoint Capital, LLC 5,180$24,8640.04%
Virtu Financial LLC 103,163$4950.04%
Anson Funds Management LP 50,000$240,0000.03%
View complete list of HUMACYTE INC shareholders